一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> Theranostics >>article
Theranostics

Theranostics

IF: 13.3
Download PDF

Autophagy-lysosome inhibitor chloroquine prevents CTLA-4 degradation of T cells and attenuates acute rejection in murine skin and heart transplantation

Published:1 July 2020 DOI: 10.7150/thno.43507 PMID: 32724457
Jikai Cui, Jizhang Yu, Heng Xu, Yanqiang Zou, Hao Zhang, Shanshan Chen, Sheng Le, Jing Zhao, Lang Jiang, Jiahong Xia, Jie Wu

Abstract

Background: The immune checkpoint cytotoxic T lymphocyte antigen-4 (CTLA-4), induced upon T cell activation but degraded quickly, has been targeted in the clinical therapy of advanced cancers and autoimmune diseases. However, whether inhibiting CTLA-4 degradation ameliorates transplant rejection remains unknown. Methods: The CTLA-4 expression in activated murine T cells treated with the inhibitors mediating protein degradation was detected by flow cytometry (FCM). CD45.1 mice, which received TEa T cells and underwent heart transplantation, were administrated with the inhibitor. Subsequently, CTLA-4 expression of TEa T cells was analyzed. Murine skin and heart transplantation models were built, then the survival and histopathology of the allografts, and T cell subsets in the spleens of each group were compared. Results: Chloroquine (CQ) was identified as an inhibitor of CTLA-4 degradation, which augmented both surface and total CTLA-4 expression in T cells. It considerably prolonged the skin and heart allograft survival time and reduced the infiltration of inflammatory cells in allografts. Besides decreasing the frequencies of the CD4+ and CD8+ effector T cells, especially IFN-γ producing T cells, CQ also increased the proportion of regulatory T cells in the spleen. The CTLA-4 blockade abrogated the benefits of CQ on the survival of heart allografts. Moreover, CQ enhanced CTLA-4 expression in activated human T cells and reduced the secretion of IFN-γ in human mixed lymphocyte reaction. Conclusion: Targeting CTLA-4 degradation provides a novel means to prevent transplant rejection and induce transplant tolerance.

Substances (4)

Materials
Procduct Name CAS Molecular Formula Supplier Price
ipilimumab 477202-00-9 103 suppliers Inquiry
ipilimumab 477202-00-9 103 suppliers Inquiry
ipilimumab 477202-00-9 103 suppliers Inquiry
ipilimumab 477202-00-9 103 suppliers Inquiry

Similar articles

IF:2.8

A small erythropoietin derived non-hematopoietic peptide reduces cardiac inflammation, attenuates age associated declines in heart function and prolongs healthspan.

Frontiers in Cardiovascular Medicine Nolan M Winicki, Alay P Nanavati,etc Published: 1 January 2022
IF:0

Teneligliptin: DPP-4 inhibitor in the treatment of type II Diabetes Mellitus

International Journal of Phytopharmacy K. Danao, M. Shende,etc Published: 30 August 2017
遂溪县| 凌云县| 克东县| 德格县| 英吉沙县| 普兰店市| 龙游县| 龙游县| 安新县| 延吉市| 阿拉善右旗| 泊头市| 吉木萨尔县| 葫芦岛市| 盘山县| 韩城市| 盐津县| 余干县| 东乡| 济南市| 龙胜| 电白县| 西宁市| 静海县| 铜山县| 永丰县| 楚雄市| 兴城市| 安吉县| 鱼台县| 新建县| 龙江县| 错那县| 株洲县| 方正县| 宣化县| 长宁县| 确山县| 庆元县| 民勤县| 江门市|